GLP-1 Guides: Ozempic, Mounjaro and Wegovy (Page 2)

Weight Loss Pills and GLP-1 Injections: What to Know

How prescription weight loss pills compare with GLP-1 injections: what each is approved for, how it is dosed, and what the labels say about risks.

Retatrutide is an investigational triple-agonist injection, not approved anywhere. What phase 2 and phase 3 trials report, and what is still unknown.

Saxenda (liraglutide 3 mg) is a daily injection for weight management. See who it is for, the label's dose steps, side effects and how it differs.

Tirzepatide activates GIP and GLP-1 receptors. See what Zepbound and Mounjaro are approved for, label dosing, trial results and side effects.

Zepbound (tirzepatide) vs Wegovy (semaglutide): approved uses, dosing, head-to-head trial results, and side effects, from the FDA labels.

The Wegovy pill is a daily oral semaglutide for adult weight management. See the label's dose steps, how to take it, trial results and side effects.

Mounjaro (tirzepatide) vs Ozempic (semaglutide): approved uses, dosing, head-to-head trial results, side effects, and how to track either one.

Ozempic and Wegovy both contain semaglutide. Compare approved uses, doses, dosing schedules and side effects, based on the FDA labels.

What Mounjaro (tirzepatide) is approved for, how its GIP and GLP-1 action works, the dosing schedule, and the side effects listed on its label.